Board of Directors
Anjen Chenn, M.D.-Ph.D. is a physician-scientist and Associate Professor of Pathology at the University of Illinois, Chicago.
Anjen received his A.B., summa cum laude in biochemical sciences at Harvard University and his M.D. and Ph.D. in neurosciences from Stanford University. He completed his residency in clinical pathology at the Brigham and Women’s Hospital in Boston, Massachusetts and was Howard Hughes Medical Institute Physician Postdoctoral Fellow in the lab of Dr. Christopher Walsh at Beth Israel Deaconess Medical Center in Boston and an instructor at Harvard Medical School. He then became Assistant Professor at Northwestern University Feinberg School of Medicine and ran a research lab studying developmental brain disorders and brain cancer and performed clinical work as director of molecular diagnostics at Northwestern Memorial Hospital in Chicago. Anjen’s research laboratory received funding
John Doux, M.D. is a practicing dermatologist and analyst at Palo Alto Investors.
John obtained a B.S. with distinction and an M.D. from Stanford University, where he was a Howard Hughes Medical Institute Fellow performing research in the laboratory of Dr. David Woodley. After an internship at Brigham and Women’s Hospital in Boston, he returned to Stanford to complete his residency training in dermatology. He also completed an M.B.A. at the Wharton School of Business where he was a Palmer Scholar. Since 2004 he has been an analyst at Palo Alto Investors, an investment fund specializing in healthcare with $1B in assets under management, where he specializes in the healthcare sector. He also serves as a Director at Brickell Biotech, Inc. John is board certified in dermatology. John has an extensive background teaching students and resident physicians and fellows at Stanford Medical School and Harvard Medical School.
Jonathan I. Lieber is Chief Financial Officer at Histogenics Corporation.
Jon received a B.S. in Business Administration and Finance from Boston University and an M.B.A. in finance from New York University Stern School of Business. He was an investment banker for 10 years where he originated and executed on numerous corporate financings and merger and acquisition transactions at SG Cowen and Salomon Brothers Inc. Jon became Vice President of Finance of Altus Pharmaceuticals Inc. in 2002 and also served as its Treasurer from September 2005 to March 27, 2009 where he led all public and private capital raising activities at the company, including its $110 million initial public offering and a subsequent $90 million follow-on offering.
Scientific and Technical Advisors
Maarten C. Bosland, D.V.Sc., Ph. D. is Professor of Pathology at University of Illinois, Chicago (UIC).
Maarten graduated from the University of Utrecht (The Netherlands) in 1978 with a Doctoral Degree in Veterinary Science (DVSc) and received in 1989 a Doctorate Degree (PhD) in Experimental Pathology from the same University. He is a Board Certified in Laboratory Animal Pathology and Laboratory Animal Science (in The Netherlands). He was Research Scientist-Toxicologic Pathologist at TNO, Zeist, The Netherlands from 1978-1988. From 1985-2006, he has been on the Faculty of the Department of Environmental Medicine of New York University (NYU) School of Medicine, since 2000 as Professor of Environmental Medicine and Urology. Since 2006, he has been Professor and Director of Graduate Studies in the Department of Pathology at the University of Illinois at Chicago (UIC) College of Medicine. He has published over 155 articles and book chapters about his research, which has focused on prostate cancer, chemoprevention of cancer, and hormonal carcinogenesis. His current research interests include mechanisms of hormonal prostate carcinogenesis, particularly the role of estrogens and androgens, prostate cancer chemoprevention, and preclinical research and human clinical trials of chemoprevention by natural substances, in particular dietary antioxidants, soy, and soy isoflavones. He has directed a satellite animal facility and a histopathology facility at NYU. He has served on the Animal Care Committees and on Graduate Student Steering Committees at NYU and UIC. He has also served on expert panel committees of the WHO (for the International Agency for Research on Cancer) and the US National Academy of Science. He is currently also involved in capacity building in pathology in Ghana, teaching medical students in Ghana, and collaborative research on prostate cancer and anticancer properties of West African medicinal plants with investigators at universities in Nigeria and Ghana. In 2014, Maarten established a collaborative program between UIC and the Korle-Bu Teaching Hospital (KBTH) in Accra and Komfo Anyoke Teaching Hospital (KATH) in Kumasi in Ghana to assist in the pathology residency training programs accredited by the Ghana College of Physicians and Surgeons. Ghana, a country of 26 million people, has fewer than 15 pathologists. Maarten’s program utilizes cutting-edge telepathology and teleconferencing to provide remote consultation and case conference review in resident training sessions with UIC pathologists.
Ian Gilman is a Freelance Creator and Digital Renaissance Man